FibroBiologics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGM:FBLG Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Role	Shares	Max Price
12 Aug 24	BuyUS$19,000	Hamid Khoja	Individual		10,000	US$1.90
12 Aug 24	BuyUS$16,269	Peter O’Heeron	Individual		8,500	US$1.91

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of FBLG?
Owner Type	Number of Shares	Ownership Percentage
Private Companies	2,125,001	6.13%
Institutions	5,502,635	15.9%
Individual Insiders	7,668,342	22.1%
General Public	19,363,147	55.9%

Dilution of Shares: FBLG only recently listed within the past 12 months

Top Shareholders

Top 25 shareholders own 42.48% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
17%	Peter O’Heeron	5,906,647	US$13.6m	-2.48%	no data
6.13%	Golden Knight Incorporated, L.P.	2,125,001	US$4.9m	0%	no data
5.07%	BlackRock, Inc.	1,756,593	US$4.1m	91.2%	no data
2.35%	Dan Linscomb	813,610	US$1.9m	0%	no data
2.35%	Pam Linscomb	813,610	US$1.9m	0%	no data
2.23%	The Vanguard Group, Inc.	771,444	US$1.8m	249%	no data
1.73%	Geode Capital Management, LLC	599,760	US$1.4m	90%	no data
1.37%	State Street Global Advisors, Inc.	475,837	US$1.1m	26.5%	no data
0.87%	Cascade Financial Partners, LLC	302,601	US$699.0k	-3.95%	0.09%
0.61%	Northern Trust Global Investments	210,473	US$486.2k	0%	no data
0.32%	Optivise Advisory Services, LLC	110,100	US$254.3k	0%	0.16%
0.32%	Requisite Capital Management LLC	109,713	US$253.4k	0%	0.05%
0.27%	Richard Cilento	93,225	US$215.4k	0%	no data
0.25%	The American Institute for Advanced Investment Management, LLP	88,206	US$203.8k	0%	0.14%
0.21%	Bank of America Corporation, Asset Management Arm	71,867	US$166.0k	30.5%	no data
0.2%	Morgan Stanley, Investment Banking and Brokerage Investments	70,328	US$162.5k	200%	no data
0.2%	Charles Schwab Investment Management, Inc.	69,732	US$161.1k	5.21%	no data
0.15%	Cerity Partners LLC	52,100	US$120.4k	0%	no data
0.15%	BNY Asset Management	50,399	US$116.4k	-26.5%	no data
0.13%	UBS Asset Management AG	43,352	US$100.1k	-44.5%	no data
0.12%	Goldman Sachs Group, Investment Banking and Securities Investments	41,815	US$96.6k	226%	no data
0.12%	Barclays PLC Private Banking & Investment Banking Investment	39,958	US$92.3k	363%	no data
0.11%	RMR Wealth Builders, Inc.	38,260	US$88.4k	2.41%	0.01%
0.1%	Concurrent Investment Advisors, LLC	35,283	US$81.5k	0%	no data
0.1%	Teachers Insurance and Annuity Association-College Retirement Equities Fund	34,540	US$79.8k	0%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/26 00:48
End of Day Share Price	2024/12/26 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

FibroBiologics, Inc. is covered by 4 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Jason Kolbert	D. Boral Capital LLC.
Matthew Caufield	H.C. Wainwright & Co.
Michael Okunewitch	Maxim Group